2-Amino-5-arylbenzoxazole derivatives as potent inhibitors of fatty acid amide hydrolase (FAAH)

被引:14
作者
Estiarte, M. Angels [1 ]
Johnson, Russell J. [1 ]
Kaub, Carl J. [1 ]
Gowlugari, Sumithra [1 ]
O'Mahony, Donogh J. R. [1 ]
Nguyen, Margaret T. [1 ]
Emerling, Daniel E. [1 ]
Kelly, Michael G. [1 ]
Kincaid, John [1 ]
Vincent, Fabien [1 ]
Duncton, Matthew A. J. [1 ]
机构
[1] Renovis Inc, San Francisco, CA 94080 USA
关键词
ALPHA-KETOHETEROCYCLE INHIBITORS; DRUG DISCOVERY; KETOOXAZOLE INHIBITORS; EXCEPTIONALLY POTENT; THERAPEUTIC TARGET; ANANDAMIDE; ENZYME; MODULATION; OXETANES; BLOCKADE;
D O I
10.1039/c2md00307d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2,5-Disubstituted benzoxazole derivatives were evaluated for their ability to inhibit hFAAH. Structure-activity studies indicated that an isoindoline group at the 2-position of the benzoxazole ring gave rise to particularly potent inhibitors. Further refinement resulted in compounds, such as 50, with low nanomolar potencies against hFAAH. Preliminary biochemical experiments revealed that model benzoxazole FAAH inhibitors inhibited the enzyme in a manner consistent with a reversible mechanism. Additionally, the species dependency of FAAH inhibition was measured. Of the species tested, inhibition of rabbit FAAH, but not rat and guinea pig FAAH, appeared to show close alignment to human FAAH. These results may suggest similarities between the active sites of the FAAH enzyme for these two species, and may also suggest that rabbit could be a viable species with which to conduct preclinical testing with benzoxazole FAAH inhibitors.
引用
收藏
页码:611 / 619
页数:9
相关论文
共 88 条
  • [1] ADAMS ROGER, 1940, SCIENCE, V92, P115, DOI 10.1126/science.92.2380.115
  • [2] Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders
    Ahn, Kay
    Johnson, Douglas S.
    Cravatt, Benjamin F.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (07) : 763 - 784
  • [3] Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
    Ahn, Kay
    Johnson, Douglas S.
    Mileni, Mauro
    Beidler, David
    Long, Jonathan Z.
    McKinney, Michele K.
    Weerapana, Eranthie
    Sadagopan, Nalini
    Liimatta, Marya
    Smith, Sarah E.
    Lazerwith, Scott
    Stiff, Cory
    Kamtekar, Satwik
    Bhattacharya, Keshab
    Zhang, Yanhua
    Swaney, Stephen
    Van Becelaere, Keri
    Stevens, Raymond C.
    Cravatt, Benjamin F.
    [J]. CHEMISTRY & BIOLOGY, 2009, 16 (04): : 411 - 420
  • [4] Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity
    Ahn, Kyunghye
    Johnson, Douglas S.
    Fitzgerald, Laura R.
    Liimatta, Marya
    Arendse, Andrea
    Stevenson, Tracy
    Lund, Eric. T.
    Nugent, Richard A.
    Nomanbhoy, Tyzoon K.
    Alexander, Jessica P.
    Cravatt, Benjamin F.
    [J]. BIOCHEMISTRY, 2007, 46 (45) : 13019 - 13030
  • [5] Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
    Boger, DL
    Sato, H
    Lerner, AE
    Hedrick, MP
    Fecik, RA
    Miyauchi, H
    Wilkie, GD
    Austin, BJ
    Patricelli, MP
    Cravatt, BF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5044 - 5049
  • [6] Discovery of a potent, selective, and efficacious class of reversible α-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics
    Boger, DL
    Miyauchi, H
    Du, W
    Hardouin, C
    Fecik, RA
    Cheng, H
    Hwang, I
    Hedrick, MP
    Leung, D
    Acevedo, O
    Guimaraes, CRW
    Jorgensen, WL
    Cravatt, BF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1849 - 1856
  • [7] Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: A probe of structural and conformational features contributing to inhibition
    Boger, DL
    Sato, H
    Lerner, AE
    Austin, BJ
    Patterson, JE
    Patricelli, MP
    Cravatt, BF
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) : 265 - 270
  • [8] α-Keto heterocycle inhibitors of fatty acid amide hydrolase:: Carbonyl group modification and α-substitution
    Boger, DL
    Miyauchi, H
    Hedrick, MP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (12) : 1517 - 1520
  • [9] Oxetanes as Versatile Elements in Drug Discovery and Synthesis
    Burkhard, Johannes A.
    Wuitschik, Georg
    Rogers-Evans, Mark
    Mueller, Klaus
    Carreira, Erick M.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (48) : 9052 - 9067
  • [10] A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo
    Clapper, Jason R.
    Vacondio, Federica
    King, Alvin R.
    Duranti, Andrea
    Tontini, Andrea
    Silva, Claudia
    Sanchini, Silvano
    Tarzia, Giorgio
    Mor, Marco
    Piomelli, Daniele
    [J]. CHEMMEDCHEM, 2009, 4 (09) : 1505 - 1513